MedCap AB (publ) (STO:MCAP)
Sweden flag Sweden · Delayed Price · Currency is SEK
561.00
+8.00 (1.45%)
Nov 2, 2026, 5:24 PM CET

MedCap AB Revenue

MedCap AB had revenue of 566.70M SEK in the quarter ending September 30, 2026, with 13.00% growth. This brings the company's total for the last twelve months to 2.32B, up 16.54% year-over-year. In the year 2025, MedCap AB had annual revenue of 2.11B with 16.68% growth. That makes MedCap AB the 16,114th largest company in the world by revenue and 204th in Sweden.

Revenue (ttm)
2.32B
Revenue Growth
+16.54%
P/S Ratio
3.49
Revenue / Employee
3.58M
Employees
663
Market Cap
8.40B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Assistive Tech 981.80M 46.6%
  • Medtech 689.60M 32.7%
  • Specialty Pharma 436.60M 20.7%

By Geography

Chart
  • Sweden 957.30M 45.4%
  • Nordic (ex-Sweden) 612.50M 29.1%
  • Europe (ex-Nordic) 484.60M 23.0%
  • Rest of the World 53.70M 2.5%
Fiscal year ended Dec 31, 2025 See the full MedCap AB breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.11B301.30M16.68%
Dec 31, 20241.81B219.30M13.82%
Dec 31, 20231.59B476.10M42.84%
Dec 31, 20221.11B195.00M21.28%
Dec 31, 2021916.30M98.90M12.10%
Dec 31, 2020817.40M60.30M7.96%
Dec 31, 2019757.10M48.10M6.78%
Dec 31, 2018709.00M113.20M19.00%
Dec 31, 2017595.80M-255.87M-30.04%
Apr 30, 2017851.67M34.75M4.25%
Apr 30, 2016816.92M-35.84M-4.20%
Apr 30, 2015852.75M26.67M3.23%
Apr 30, 2014826.09M477.05M136.67%
Apr 30, 2013349.04M41.64M13.54%
Apr 30, 2012307.41M-8.48M-2.68%
Apr 30, 2011315.89M57.10M22.06%
Apr 30, 2010258.79M71.73M38.35%
Apr 30, 2009187.06M-1.80M-0.95%
Apr 30, 2008188.86M100.18M112.98%
Apr 30, 200788.68M77.70M708.19%
Dec 31, 200510.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Getinge AB34.46B
Elekta AB16.61B
Nolato AB9.58B
Sectra AB3.74B
Vitrolife AB3.44B
BICO Group AB1.50B
Xvivo Perfusion AB958.65M
CellaVision AB763.02M
Revenue Rankings